Tissue Analysis Services for Brain Tumors

The treatment of brain tumors is complex and highly heterogeneous. All stages of the disease may occur in the same injury, with the spread of transitions between regions of pathological tissue (i.e., active tumor, necrosis, and meninges). Traditional MRI methods, although able to image brain tissue noninvasively, provide clinical information on the localization and characterization of lesions. However, the current reliance on the physician's naked eye to identify tumor tissue in MRI images is time-consuming and inefficient and relies heavily on physicians experienced in diagnostic imaging. Therefore, the use of more diversified and advanced technologies to improve the efficiency of brain tumor identification and the accuracy of lesion segmentation has a high clinical application value.

We provide tissue analysis services for brain tumors

To treat brain tumors, it is necessary to understand the tissue condition of brain tumors first. However, brain tissues are fragile and complex, and traditional tissue biopsy methods are not effective for brain tumors. Therefore, Alfa Cytology offers brain tumor tissue microarrays, organoids, and organ microarrays to our customers. Based on our services, we expect to provide our clients with repeated and dynamic monitoring of brain tumor changes, providing more accurate guidance for the development and updating of treatment plans for brain tumor patients.

Most of the accurate molecular pathology information of tumors comes from stereotactic biopsies, but the anatomical location of the brain makes tissue biopsy extremely risky, and the slightest mistake can bring unpredictable consequences to patients. Alfa Cytology provides a more efficient and faster method for brain tumor detection, enabling rapid and accurate identification of brain tumor tissue. Please contact our staff to learn how we can provide new ideas for the clinical precision treatment of brain tumor disease.